New asthma clinical trial: Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)

Published on: September 16, 2020 at 07:00PM
Condition:   Asthma
Intervention:   Drug: Dupilumab SAR231893
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Not yet recruiting